title: Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.
abstract: In the past years there has been an increasing incidence of invasive fungal infections, particularly in immunocompromised patients. These infections continue to pose a diagnostic and therapeutic challenge. Considering these facts, the authors report a clinical case of invasive pulmonary aspergillosis which illustrates the improved outcomes associated with the extended-spectrum triazole, voriconazole, used in first-line therapy.
authors: Pulmonology Department, Portuguese Oncology Institute, Porto, Portugal. sandrasaleiro@portugalmail.pt
authors: Sandra
authors: S
authors: Saleiro
authors: Luís
authors: L
authors: Rocha
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D055744:Invasive Pulmonary Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage; D013736:Testicular Neoplasms / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole